SAT-1 -1415T/C polymorphism and susceptibility to schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 2, 2009, Pages 345-348

  Bermudo Soriano, Carlos Riaza ^a   Vaquero Lorenzo, Concepcion ^b,c   Diaz Hernandez, Montserrat ^b,c   Perez Rodriguez, M Mercedes ^d,e   Fernandez Piqueras, Jose ^b,c   Saiz Ruiz, Jeronimo ^a,f   Baca Garcia, Enrique ^b,e,g  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^d MOUNT SINAI MEDICAL CENTER   (United States)

^e HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ   (Spain)

^f UNIVERSITY OF ALCALÁ   (Spain)

^g NewYork Presbyterian Hospital   (United States)

Author keywords

Genetics; Polyamines; Psychosis; SAT 1; Schizophrenia

Indexed keywords

CYTOSINE; N1 ACETYLSPERMIDINE; THYMINE;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PROMOTER REGION; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ACETYLTRANSFERASES; ADULT; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK; SCHIZOPHRENIA; SPAIN;

EID: 60049087271     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.12.015     Document Type: Article

References (40)

1. Belle N.A., Dalmolin G.D., Fonini G., Rubin M.A., and Rocha J.B. Polyamines reduces lipid peroxidation induced by different pro-oxidant agents. Brain Res 1008 (2004) 245-251
2. Berlese D.B., Sauzemm P.D., Carati M.C., Guerra G.P., Stiegemeier J.A., Mello C.F., et al. Time-dependent modulation of inhibitory avoidance memory by spermidine in rats. Neurobiol Learn Mem 83 (2005) 48-53
3. Cohen J. Statistical power analysis for the behavioral sciences (1988), Lawrence Erlbaum Associates, Inc.
4. Conti F., and Weinberg R.J. Shaping excitation at glutamatergic synapses. Trends Neurosci 22 (1999) 451-458
5. Das D., De Fonseka N., and Das I. Interactions of nitric oxide, free radicals and polyamines in the membrane pathology of schizophrenia. Biochem Soc Trans 26 (1998) S143
6. Das I., Ramchand C.N., Gliddon A., and Hirsch S.R. Nitric oxide, free radicals and polyamines may have a role in the membrane pathology of schizophrenia. Neuropsychobiology 37 (1998) 65-67
7. Fiori L.M., and Turecki G. Implication of the polyamine system in mental disorders. J Psychiatry Neurosci 33 (2008) 102-110
8. Gilad G.M., Gilad V.H., Casanova M.F., and Casero J. Polyamines and their metabolizing enzymes in human frontal cortex and hippocampus: preliminary measurements in affective disorders. Biol Psychiatry 38 (1995) 227-234
9. Goff D.C., and Coyle J.T. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry 158 (2001) 1367-1377
10. Guidotti A., Ruzicka W., Grayson D.R., Veldic M., Pinna G., Davis J.M., et al. S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis. Neuroreport 18 (2007) 57-60
11. Guipponi M, Deutsch S, Kohler K, Perroud N, Le Gal F, Vessaz M, et al. Genetic and epigenetic analysis of SSAT gene dysregulation in suicidal behavior. AmJ Med Genet Part B. doi:10.1002/ajmg.b.30901.
12. Hirsch S.R., Richardson-Andrews R., Costall B., Kelly M.E., de Belleroche J., and Naylor R.J. The effects of some polyamines on putative behavioural indices of mesolimbic versus striatal dopaminergic function. Psychopharmacology (Berl) 93 (1987) 101-104
13. Ingi T., Worley P.F., and Lanahan A.A. Regulation of SSAT expression by synaptic activity. Eur J Neurosci 13 (2001) 1459-1463
14. Janne J., Alhonen L., Pietila M., Keinanen T.A., Uimari A., Hyvonen M.T., et al. Genetic manipulation of polyamine catabolism in rodents. J Biochem (Tokyo) 139 (2006) 155-160
15. Kishi A., Ohno M., and Watanabe S. Concurrent activation of hippocampal glycine and polyamine sites of the N-methyl-d-aspartate receptor synergistically reverses working memory deficits in rats. Neurosci Lett 257 (1998) 131-134
16. Li H., Meininger C.J., Hawker Jr. J.R., Haynes T.E., Kepka-Lenhart D., Mistry S.K., et al. Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells. Am J Physiol Endocrinol Metab 280 (2001) E75-E82
17. Lobo A., Perez-Echeverria M.J., and Artal J. Validity of the scaled version of the General Health Questionnaire (GHQ-28) in a Spanish population. Psychol Med 16 (1986) 135-140
18. Masuko T., Kusama-Eguchi K., Sakata K., Kusama T., Chaki S., Okuyama S., et al. Polyamine transport, accumulation, and release in brain. J Neurochem 84 (2003) 610-617
19. Middleton F.A., Mirnics K., Pierri J.N., Lewis D.A., and Levitt P. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci 22 (2002) 2718-2729
20. Nishimura K., Nakatsu F., Kashiwagi K., Ohno H., Saito T., and Igarashi K. Essential role of S-adenosylmethionine decarboxylase in mouse embryonic development. Genes Cells 7 (2002) 41-47
21. Pellegrini-Giampietro D.E. An activity-dependent spermine-mediated mechanism that modulates glutamate transmission. Trends Neurosci 26 (2003) 9-11
22. Pfeiffer C.C., Iliev V., Goldstein L., Jenney E.H., and Schultz R. Blood histamine, polyamines and the schizophrenias. Computer correlations of the low and high blood histamine types. Res Commun Chem Pathol Pharmacol 1 (1970) 247-265
23. Ramchand C.N., Das I., Gliddon A., and Hirsch S.R. Role of polyamines in the membrane pathology of schizophrenia. A study using fibroblasts from schizophrenic patients and normal controls. Schizophr Res 13 (1994) 249-253
24. Role L.W., and Berg D.K. Nicotinic receptors in the development and modulation of CNS synapses. Neuron 16 (1996) 1077-1085
25. Salvi M., and Toninello A. Effects of polyamines on mitochondrial Ca(2+) transport. Biochim Biophys Acta 1661 (2004) 113-124
26. Seiler N. Catabolism of polyamines. Amino Acids 26 (2004) 217-233
27. Seiler N., and Atanassov C.L. The natural polyamines and the immune system. Prog Drug Res 43 (1994) 87-141
28. Seiler N., and Raul F. Polyamines and apoptosis. J Cell Mol Med 9 (2005) 623-642
29. Sequeira A., Gwadry F.G., Ffrench-Mullen J.M., Canetti L., Gingras Y., Casero Jr. R.A., et al. Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch Gen Psychiatry 63 (2006) 35-48
30. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 Suppl 20 (1998) 22-33
31. Shin J., Shen F., and Huguenard J.R. Polyamines modulate AMPA receptor-dependent synaptic responses in immature layer v pyramidal neurons. J Neurophysiol 93 (2005) 2634-2643
32. Svinarev V.I. [Polyamine studies of schizophrenia patients]. Vrach Delo (1986) 88-89
33. Takano K., Ogura M., Nakamura Y., and Yoneda Y. Neuronal and glial responses to polyamines in the ischemic brain. Curr Neurovasc Res 2 (2005) 213-223
34. Takano K., Ogura M., Yoneda Y., and Nakamura Y. Oxidative metabolites are involved in polyamine-induced microglial cell death. Neuroscience (2005)
35. Tomitori H., Nenoi M., Mita K., Daino K., Igarashi K., and Ichimura S. Functional characterization of the human spermidine/spermine N(1)-acetyltransferase gene promoter. Biochim Biophys Acta 1579 (2002) 180-184
36. Traynelis S.F., Hartley M., and Heinemann S.F. Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines. Science 268 (1995) 873-876
37. Vaquero-Lorenzo C., Riaza Bermudo-Soriano C., Pérez-Rodríguez M.M., Díaz-Hernández M., López-Castromán J., Fernández-Piqueras J., et al. Positive association between SAT-1 -1415T/C polymorphism and anxiety. Am J Med Genet Part B (Neuropsychiatric Genet) (2008) 1-4
38. Wallace H.M., Fraser A.V., and Hughes A. A perspective of polyamine metabolism. Biochem J 376 (2003) 1-14
39. Wang Y., Devereux W., Stewart T.M., and Casero Jr. R.A. Characterization of the interaction between the transcription factors human polyamine modulated factor (PMF-1) and NF-E2-related factor 2 (Nrf-2) in the transcriptional regulation of the spermidine/spermine N1-acetyltransferase (SSAT) gene. Biochem J 355 (2001) 45-49
40. Xiao L., Celano P., Mank A.R., Griffin C., Jabs E.W., Hawkins A.L., et al. Structure of the human spermidine/spermine N1-acetyltransferase gene (exon/intron gene organization and localization to Xp22.1). Biochem Biophys Res Commun 187 (1992) 1493-1502